Evaluation of new classifications of N descriptor in non-small cell lung cancer (NSCLC) based on the number and the ratio of metastatic lymph nodes
作者： Konrad Pawełczyk , Marek Marciniak , Piotr Błasiak
DOI: 10.1186/S13019-016-0456-5
关键词:
摘要: Background The aim of the study was to evaluate prognostic power new classifications N descriptor created basing on number (NLN) and ratio metastatic lymph nodes (RLN) in NSCLC compared current classification (CLN).
biomedcentral.com
springer.com
core.ac.uk
paperity.org参考文章(25)
Mecedes Canela Cardona, José A. Maestre Alcácer, Manuel Wong Jaen, Laura Romero Vielva, State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter? Translational lung cancer research. ,vol. 3, pp. 95- 99 ,(2014) , 10.3978/J.ISSN.2218-6751.2014.02.01
Peschaud Frédérique, Benoist Stéphane, Julié Catherine, Beauchet Alain, Penna Christophe, Rougier Philippe, Bernard Nordlinger, The Ratio of Metastatic to Examined Lymph Nodes Is a Powerful Independent Prognostic Factor in Rectal Cancer Annals of Surgery. ,vol. 248, pp. 1067- 1073 ,(2008) , 10.1097/SLA.0B013E31818842EC
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Vincent Vinh-Hung, Claire Verschraegen, Donald I Promish, Gábor Cserni, Jan Van de Steene, Patricia Tai, Georges Vlastos, Mia Voordeckers, Guy Storme, Melanie Royce, Ratios of involved nodes in early breast cancer. Breast Cancer Research. ,vol. 6, pp. 1- 9 ,(2004) , 10.1186/BCR934
Marc Riquet, Jalal Assouad, Patrick Bagan, Christophe Foucault, Françoise Le Pimpec Barthes, Antoine Dujon, Claire Danel, Skip Mediastinal Lymph Node Metastasis and Lung Cancer: A Particular N2 Subgroup With a Better Prognosis The Annals of Thoracic Surgery. ,vol. 79, pp. 225- 233 ,(2005) , 10.1016/J.ATHORACSUR.2004.06.081
C DODDOLI, A ARAGON, F BARLESI, B CHETAILLE, S ROBITAIL, R GIUDICELLI, P FUENTES, P THOMAS, Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? European Journal of Cardio-Thoracic Surgery. ,vol. 27, pp. 680- 685 ,(2005) , 10.1016/J.EJCTS.2004.12.035
Jan P. van Meerbeeck, Veerle F.M. Surmont, Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments Lung Cancer. ,vol. 65, pp. 257- 267 ,(2009) , 10.1016/J.LUNGCAN.2009.02.007
Frank Detterbeck, What to do with “Surprise” N2?: Intraoperative Management of Patients with Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 3, pp. 289- 302 ,(2008) , 10.1097/JTO.0B013E3181630EBD
Hyun Jin Cho, Sung Ryong Kim, Hyeong Ryul Kim, Jin-Ok Han, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Modern outcome and risk analysis of surgically resected occult N2 non-small cell lung cancer. The Annals of Thoracic Surgery. ,vol. 97, pp. 1920- 1925 ,(2014) , 10.1016/J.ATHORACSUR.2014.03.004
Takayuki Fukui, Shoichi Mori, Kohei Yokoi, Tetsuya Mitsudomi, Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 1, pp. 120- 125 ,(2006) , 10.1016/S1556-0864(15)31526-4